Clinical trial
Antiplatelet Therapy in Secondary Prevention for Patient With Silent Brain Infarction
NCT03318744 is registered in ClinicalTrials.gov with First People's Hospital of Shenyang as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Antiplatelet Therapy in Secondary Prevention for Patient With Silent Brain Infarction
- Lead sponsor
- First People's Hospital of Shenyang
- Phase
- Not applicable
- Overall status
- Unknown status
- Start date
- January 31, 2018
- Completion date
- December 31, 2021
- Enrollment
- 3,400 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.